SCHEMBL7700700

SCHEMBL7700700

O=C(N[C@@H](Cc1ccccc1)C(=O)CNS(=O)(=O)c1ccccc1)c1ccc(Nc2ccc3ccccc3c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.52
CA1 P00915 2/20 0.48
KAT6A Q92794 1/20 0.47
ITGB1 P05556 1/20 0.46
ITGA4 P13612 1/20 0.46
MMP9 P14780 2/20 0.46
ACE P12821 2/20 0.46
PLAT P00750 1/20 0.45
USP30 Q70CQ3 1/20 0.44
CASP1 P29466 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 1/20 0.44
CA12 O43570 1/20 0.43
CA9 Q16790 1/20 0.43
F2 P00734 1/20 0.43
PTPN1 P18031 1/20 0.43
PIN1 Q13526 1/20 0.42
CTSL P07711 1/20 0.42
CTSB P07858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7703565 0.91 CA2 (0.51) CA2CA1KAT6AMMP9PLAT
SCHEMBL7698087 0.89 CA2 (0.51) CA2CA1KAT6AACEMEN1
SCHEMBL7702126 0.89 PLAT (0.45) CA2CA1KAT6AMMP9PLAT
SCHEMBL7684139 0.86 CA2 (0.48) CA2CA1KAT6AACEALDH1A1
SCHEMBL7701695 0.84 CA2 (0.52) CA2ITGB1ITGA4MMP9ACE
SCHEMBL7692550 0.83 AKR1C3 (0.51) CA2KAT6APLATMEN1ALDH1A1
SCHEMBL7704769 0.83 CA2 (0.52) CA2CA1KAT6AITGB1ITGA4
SCHEMBL7706585 0.82 ALDH1A1 (0.53) CA2CA1KAT6APLATUSP30
SCHEMBL7701518 0.81 CA2 (0.44) CA2CA1KAT6AITGB1ITGA4
SCHEMBL7695272 0.80 ALDH1A1 (0.52) CA2CA1KAT6AMMP9ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed